Evaluation of Implementation of the Phoenix PrEP (Pre-Exposure Prophylaxis) Access Project for Youth Aged 13-24
- Conditions
- Unsafe SexIV Drug Usage
- Registration Number
- NCT03637322
- Lead Sponsor
- Phoenix Children's Hospital
- Brief Summary
This study will evaluate the implementation of a PrEP program for youth aged 13-24 in Phoenix, AZ. Numbers of youth who initiate PrEP, how long they continue with PrEP, and the barriers for youth who are trying to initiate and continue taking PrEP will be examined.
- Detailed Description
This observational study will describe the barriers encountered and the benefits found as youth engage in a PrEP program, the Phoenix PrEP Access Project and as they participate in PrEP provided through standard medical care. This study does not investigate the safety, efficacy or other medical benefits of PrEP, but looks at the issues surrounding youth who are trying to access PrEP.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PrEP Uptake 3 years Uptake of PrEP offered to youth presenting for PrEP ages 13-24
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Phoenix Children's Hospital, Bill Holt Clinic
🇺🇸Phoenix, Arizona, United States